Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therap...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Burroughs, A K, Groszmann, R, Bosch, J, Grace, N, Garcia-Tsao, G, Patch, D, Garcia-Pagan, J C, Dagher, L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Copyright 2002 by Gut 2002
Gaiak:
Occasional Viewpoint
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773121/
https://ncbi.nlm.nih.gov/pubmed/11839726
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak